DETAILS, FICTION AND DIAZEPAM 2MG PIL

Baseline evaluations of liver laboratory tests are proposed. APTIOM needs to be discontinued in patients with jaundice or other proof of major liver damage.Outcome of coadministration of the twin CYP3A4 and CYP2C19 inhibitor with fedratinib hasn't been studied.If any withdrawal response develops, consider pausing taper or expanding dose to previous